找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: High-Risk IV Medications in Special Patient Populations; Sandra Kane-Gill,Joseph Dasta Book 2011 Springer-Verlag London Limited 2011 High

[復(fù)制鏈接]
查看: 17084|回復(fù): 35
樓主
發(fā)表于 2025-3-21 20:01:48 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱High-Risk IV Medications in Special Patient Populations
編輯Sandra Kane-Gill,Joseph Dasta
視頻videohttp://file.papertrans.cn/427/426747/426747.mp4
概述The Institute for Safe Medication Practices has developed a list of high-alert medications which are medications at a heightened risk for patient harm when used in error.No book has been published on
圖書封面Titlebook: High-Risk IV Medications in Special Patient Populations;  Sandra Kane-Gill,Joseph Dasta Book 2011 Springer-Verlag London Limited 2011 High
描述Critical Care Clinicians can use general drug references (Micomedex, Lexicomp) for data on dosing of high-alert medications in special patient populations but these references are not available to all healthcare clinicians, they are expensive and they are not specific to high-alert medications or critically ill patients. Doctors, nurses and pharmacists in the hospital setting will benefit from having one resource with all of this information. The purpose of this reference manual would be to guide critical care clinicians on dosing of high-alert medications in special patient populations. The most important feature of the book will be a summary of primary literature using tables when possible. This will be useful to readers because currently a reference book does not exist that guides clinicians in these difficult dosing decisions.
出版日期Book 2011
關(guān)鍵詞High Risk; Medication; Special Patient
版次1
doihttps://doi.org/10.1007/978-0-85729-606-1
isbn_softcover978-1-4471-5868-4
isbn_ebook978-0-85729-606-1
copyrightSpringer-Verlag London Limited 2011
The information of publication is updating

書目名稱High-Risk IV Medications in Special Patient Populations影響因子(影響力)




書目名稱High-Risk IV Medications in Special Patient Populations影響因子(影響力)學(xué)科排名




書目名稱High-Risk IV Medications in Special Patient Populations網(wǎng)絡(luò)公開度




書目名稱High-Risk IV Medications in Special Patient Populations網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱High-Risk IV Medications in Special Patient Populations被引頻次




書目名稱High-Risk IV Medications in Special Patient Populations被引頻次學(xué)科排名




書目名稱High-Risk IV Medications in Special Patient Populations年度引用




書目名稱High-Risk IV Medications in Special Patient Populations年度引用學(xué)科排名




書目名稱High-Risk IV Medications in Special Patient Populations讀者反饋




書目名稱High-Risk IV Medications in Special Patient Populations讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:06:37 | 只看該作者
板凳
發(fā)表于 2025-3-22 03:08:14 | 只看該作者
地板
發(fā)表于 2025-3-22 06:53:51 | 只看該作者
Thrombolytics/Anticoagulants,f medical intervention, and 1.5% of patients experience prolonged hospitalization due to anticoagulant effects.. The most common types of medication errors regarding anticoagulant use are omission (29%), improper dose/quantity (27.9%), and prescribing (14.5%) errors..
5#
發(fā)表于 2025-3-22 12:25:21 | 只看該作者
6#
發(fā)表于 2025-3-22 15:33:01 | 只看該作者
7#
發(fā)表于 2025-3-22 17:57:53 | 只看該作者
Sandra Kane-Gill,Joseph DastaThe Institute for Safe Medication Practices has developed a list of high-alert medications which are medications at a heightened risk for patient harm when used in error.No book has been published on
8#
發(fā)表于 2025-3-22 23:33:09 | 只看該作者
http://image.papertrans.cn/h/image/426747.jpg
9#
發(fā)表于 2025-3-23 05:11:47 | 只看該作者
10#
發(fā)表于 2025-3-23 07:01:53 | 只看該作者
James C. Coons,Sandeep Devabhakthunin, Litzen, B?nder, Zwirn. In der Abteilung F?rberei wurde unter Beteiligung der direkt betroffenen Fachkr?fte ein Computersystem zur Farbdatenverarbeitung eingeführt. Traditionell verrichten die F?rber dieser Abteilung eine vorwiegend handwerkliche T?tigkeit, in der Geschick, Wissen um Rezepturen un
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 14:09
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
年辖:市辖区| 怀来县| 甘孜县| 文化| 太康县| 嵊泗县| 兰西县| 将乐县| 墨竹工卡县| 隆尧县| 高雄县| 得荣县| 潼南县| 威远县| 渝中区| 夏津县| 兴安盟| 怀来县| 玛纳斯县| 延川县| 卢氏县| 景东| 蓬安县| 安溪县| 长白| 南岸区| 根河市| 南部县| 唐海县| 孝感市| 丰原市| 临高县| 阳泉市| 杭州市| 洛隆县| 阜平县| 威信县| 板桥市| 通渭县| 山东| 榆社县|